Format

Send to

Choose Destination
Int J Cardiol. 2018 Sep 15;267:100-106. doi: 10.1016/j.ijcard.2018.04.128.

Increased plasma trimethylamine-N-oxide is associated with incident atrial fibrillation.

Author information

1
Haukeland University Hospital, Dept of Heart Disease, Bergen, Norway. Electronic address: gard@helse-bergen.no.
2
University of Bergen, Dept of Global Public Health and Primary Care, Bergen, Norway.
3
University of Bergen, Dept of Clinical Science, Bergen, Norway.
4
Haukeland University Hospital, Dept of Heart Disease, Bergen, Norway.
5
Innlandet Hospital Trust, Hamar-Elverum Hospital Division, Hamar, Norway.
6
Stavanger University Hospital, Dept of Cardiology, Stavanger, Norway.
7
University of Bergen, KG Jebsen Centre for Diabetes Research, Dept of Clinical Science, Bergen, Norway.
8
Haukeland University Hospital, Dept of Heart Disease, Bergen, Norway; University of Bergen, Dept of Clinical Science, Bergen, Norway.

Abstract

BACKGROUND:

Plasma trimethylamine-N-oxide (TMAO) is associated with cardiovascular disease; however specific relationships with cardiac arrhythmias are unknown. We evaluated the association between plasma TMAO and incident atrial fibrillation (AF).

METHODS:

Risk associations were explored among 3797 patients with suspected stable angina in the Western Norway Coronary Angiography Cohort (WECAC) and verified in 3143 elderly participants in the community-based Hordaland Health Study (HUSK). Information on endpoints was obtained from nationwide registries.

RESULTS:

Median follow-up was 7.3 and 10.8 years in the WECAC and HUSK cohorts, respectively, and 412 (10.9%) and 484 (15.4%) subjects were registered with incident AF. The age and gender adjusted HRs were 1.16, 95% CI 1.05-1.28 and 1.10, 95% CI 1.004-1.19 per 1 SD increase in log-transformed plasma TMAO. Adjusting for hypertension, BMI, smoking, diabetes, or intake of total choline, a TMAO precursor, did not materially influence the risk associations. Among patients in WECAC, further extensive adjustment for other AF risk factors yielded similar results. Adding TMAO to traditional AF risk factors (age, gender, hypertension, BMI, smoking and diabetes) yielded a continuous net reclassification improvement of 0.108, 95% CI 0.015-0.202 and 0.139, 95% CI 0.042-0.235.

CONCLUSIONS:

Plasma TMAO was associated with and improved reclassification of incident AF in two independent Norwegian cohorts with long-term follow-up. The relationship was independent of traditional AF risk factors, as well as of dietary choline intake. Our findings motivate further studies to explore endogenous metabolic factors influencing the relationship between TMAO and cardiovascular disease.

KEYWORDS:

Atrial fibrillation; Biomarker; Cardiovascular disease risk factors; Choline; Trimethylamine-N-oxide

PMID:
29957250
DOI:
10.1016/j.ijcard.2018.04.128
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center